Asunto(s)
Agammaglobulinemia/inmunología , Agammaglobulinemia/virología , Enfermedades Genéticas Ligadas al Cromosoma X/inmunología , Enfermedades Genéticas Ligadas al Cromosoma X/virología , Kobuvirus/inmunología , Infecciones por Picornaviridae/inmunología , Infecciones por Picornaviridae/virología , Virosis/inmunología , Adolescente , Enfermedad Crónica , Enfermedad Injerto contra Huésped/inmunología , Enfermedad Injerto contra Huésped/virología , Trasplante de Células Madre Hematopoyéticas/métodos , Humanos , Masculino , Virosis/virologíaAsunto(s)
Infecciones por Virus de Epstein-Barr/diagnóstico , Enfermedades Genéticas Ligadas al Cromosoma X/diagnóstico , Enfermedades Genéticas Ligadas al Cromosoma X/genética , Trastornos Linfoproliferativos/diagnóstico , Trastornos Linfoproliferativos/genética , Proteína Inhibidora de la Apoptosis Ligada a X/genética , Adolescente , Agammaglobulinemia/diagnóstico , Agammaglobulinemia/patología , Anticuerpos Antivirales/sangre , Linfocitos B/citología , Linfocitos B/inmunología , Femenino , Enfermedades Genéticas Ligadas al Cromosoma X/virología , Herpesvirus Humano 4/inmunología , Herpesvirus Humano 4/aislamiento & purificación , Humanos , Recuento de Linfocitos , Trastornos Linfoproliferativos/virologíaAsunto(s)
Agammaglobulinemia/tratamiento farmacológico , Antivirales/uso terapéutico , Enfermedades Genéticas Ligadas al Cromosoma X/tratamiento farmacológico , Hepatitis C Crónica/tratamiento farmacológico , 2-Naftilamina , Administración Oral , Adulto , Agammaglobulinemia/sangre , Agammaglobulinemia/virología , Anilidas/uso terapéutico , Carbamatos/uso terapéutico , Ciclopropanos , Enfermedades Genéticas Ligadas al Cromosoma X/sangre , Enfermedades Genéticas Ligadas al Cromosoma X/virología , Hepacivirus , Hepatitis C Crónica/sangre , Hepatitis C Crónica/diagnóstico , Hepatitis C Crónica/virología , Humanos , Imidazoles/uso terapéutico , Inmunoglobulina G/sangre , Inmunoglobulinas Intravenosas/uso terapéutico , Lactamas Macrocíclicas , Compuestos Macrocíclicos/uso terapéutico , Persona de Mediana Edad , Prolina/análogos & derivados , Pirrolidinas , Ritonavir/uso terapéutico , Sofosbuvir/uso terapéutico , Sulfonamidas/uso terapéutico , Uracilo/análogos & derivados , Uracilo/uso terapéutico , Valina/análogos & derivadosRESUMEN
MicroRNAs (miRNAs) are short, single stranded, non-coding RNA molecules. They are produced by many different species and are key regulators of several physiological processes. miRNAs are also encoded by the genomes of multiple virus families, such as herpesvirus family. In particular, miRNAs from Epstein Barr virus were found at high concentrations in different associated pathologies, such as Burkitt's lymphoma, Hodgkin disease, and nasopharyngeal carcinoma. Thanks to their stability, these molecules could possibly serve as biomarkers for EBV-associated diseases. In this study, a stem-loop real-time PCR for miR-BART2-5p, miR-BART15, and miR-BART22 EBV miRNAs detection and quantification has been developed. Evaluation of these miRNAs in 31 serum samples (12 from patients affected by primary immunodeficiency, 9 from X-linked agammaglobulinemia and 10 from healthy subjects) has been carried out. The amplification performance showed a wide dynamic range (10(8)-10(2) copies/reaction) and sensibility equal to 10(2) copies/reaction for all the target tested. Serum samples analysis, on the other hand, showed a statistical significant higher level of miR-BART22 in primary immunodeficiency patients (P = 0.0001) compared to other groups and targets. The results confirmed the potential use of this assay as a tool for monitoring EBV-associated disease and for miRNAs expression profile analysis.
Asunto(s)
Herpesvirus Humano 4/genética , MicroARNs/sangre , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Agammaglobulinemia/sangre , Agammaglobulinemia/virología , Enfermedades Genéticas Ligadas al Cromosoma X/sangre , Enfermedades Genéticas Ligadas al Cromosoma X/virología , Herpesvirus Humano 4/aislamiento & purificación , Humanos , Síndromes de Inmunodeficiencia/sangre , Síndromes de Inmunodeficiencia/virología , Secuencias Invertidas Repetidas , MicroARNs/química , ARN Viral/sangre , ARN Viral/química , Reacción en Cadena en Tiempo Real de la Polimerasa/economía , Sensibilidad y EspecificidadRESUMEN
X-linked agammaglobulinemia (XLA) has been associated with a broad range of infections, but enteroviral disease represents one of the most damaging infections. The risk of enteroviral infection in XLA is lower now than in the setting of intramuscular immunoglobulin or in patients without immunoglobulin replacement, but the rate of infection has not declined significantly in the era of intravenous immunoglobulin replacement. Enteroviruses can cause inflammation of nearly every organ, but in XLA, infections often manifest as dermatomyositis or chronic meningoencephalitis. Difficulty and delay in recognizing symptoms and lack of specific therapy contribute to the poor outcomes. Furthermore, cerebrospinal fluid detection of enteroviruses is not very sensitive. Reluctance to perform brain biopsies can lead to significant delays. The other feature compromising outcomes is the lack of specific therapy. High-dose peripheral and intraventricular immunoglobulin have been used, but failure is still common. New antienteroviral drugs are in development and show promise for immunodeficient patients with life-threatening infections with enterovirus.
Asunto(s)
Agammaglobulinemia , Infecciones por Enterovirus , Enfermedades Genéticas Ligadas al Cromosoma X , Agammaglobulinemia/diagnóstico , Agammaglobulinemia/tratamiento farmacológico , Agammaglobulinemia/epidemiología , Agammaglobulinemia/virología , Antivirales/uso terapéutico , Encéfalo/diagnóstico por imagen , Encéfalo/virología , Preescolar , Enterovirus/genética , Enterovirus/aislamiento & purificación , Infecciones por Enterovirus/diagnóstico , Infecciones por Enterovirus/tratamiento farmacológico , Infecciones por Enterovirus/epidemiología , Infecciones por Enterovirus/virología , Enfermedades Genéticas Ligadas al Cromosoma X/diagnóstico , Enfermedades Genéticas Ligadas al Cromosoma X/tratamiento farmacológico , Enfermedades Genéticas Ligadas al Cromosoma X/epidemiología , Enfermedades Genéticas Ligadas al Cromosoma X/virología , Humanos , Imagen por Resonancia Magnética , Masculino , Éteres Fenílicos/uso terapéuticoRESUMEN
Thrombotic thrombocytopenic purpura (TTP) has not yet been reported to be associated with mutations in the Wiskott-Aldrich syndrome (WAS) gene. WAS is an X-linked recessive disorder characterized by thrombocytopenia, small platelet size, eczema, recurrent infections, and increased risk of autoimmune disorders and malignancies. A broad spectrum of mutations in the WAS protein (WASP) gene have been identified as causing the disease. In this study, we report on a 2-month-old Japanese boy who presented with cytomegalovirus (CMV) infection and TTP. The activity of von Willebrand factor cleaving metalloproteinase, ADAMTS13 was low and the antibody against ADAMTS13 was positive (3.6 Bethesda U/mL). Although TTP was improved by plasma exchange and steroid pulse therapy, thrombocytopenia persisted and regular transfusions of irradiated platelets were needed. Tiny platelets were found on a peripheral blood smear. CMV genome was positive in peripheral blood by polymerase chain reaction and the CMV viremia continued to persist despite intravenous gancyclovir therapy. Through direct sequencing of genomic DNA of the WASP gene in the patient, we identified a novel mutation of WASP gene: the seventh nucleotide in exon 11 (G) had been deleted (1345delG). This mutation causes a frameshift and a stop codon at amino acid 470. Western blotting demonstrated a truncated WAS protein. To our knowledge, this is the first report describing TTP in WAS patients with novel mutation in the WASP gene.
Asunto(s)
Exones , Enfermedades Genéticas Ligadas al Cromosoma X/genética , Mutación INDEL , Púrpura Trombocitopénica Trombótica/genética , Proteína del Síndrome de Wiskott-Aldrich/genética , Proteínas ADAM/sangre , Proteínas ADAM/genética , Proteína ADAMTS13 , Autoanticuerpos/sangre , Autoanticuerpos/genética , Citomegalovirus , Infecciones por Citomegalovirus/sangre , Infecciones por Citomegalovirus/genética , Infecciones por Citomegalovirus/terapia , Enfermedades Genéticas Ligadas al Cromosoma X/sangre , Enfermedades Genéticas Ligadas al Cromosoma X/terapia , Enfermedades Genéticas Ligadas al Cromosoma X/virología , Humanos , Lactante , Masculino , Intercambio Plasmático , Transfusión de Plaquetas , Púrpura Trombocitopénica Trombótica/sangre , Púrpura Trombocitopénica Trombótica/terapia , Púrpura Trombocitopénica Trombótica/virologíaAsunto(s)
Infecciones por Enterovirus/complicaciones , Infecciones por Enterovirus/diagnóstico , Infecciones por Moraxellaceae/diagnóstico , Pericarditis/complicaciones , Pericarditis/diagnóstico , Trastornos Respiratorios/microbiología , Trastornos Respiratorios/virología , Gasto Cardíaco , Taponamiento Cardíaco/microbiología , Taponamiento Cardíaco/cirugía , Tos/microbiología , Tos/virología , Diagnóstico Diferencial , Drenaje , Displasia Ectodérmica/diagnóstico , Displasia Ectodérmica/microbiología , Displasia Ectodérmica/virología , Servicios Médicos de Urgencia/métodos , Infecciones por Enterovirus/virología , Fiebre/microbiología , Fiebre/virología , Enfermedades Genéticas Ligadas al Cromosoma X/diagnóstico , Enfermedades Genéticas Ligadas al Cromosoma X/microbiología , Enfermedades Genéticas Ligadas al Cromosoma X/virología , Humanos , Inmunoglobulinas/uso terapéutico , Síndromes de Inmunodeficiencia/diagnóstico , Síndromes de Inmunodeficiencia/microbiología , Síndromes de Inmunodeficiencia/virología , Lactante , Masculino , Moraxella catarrhalis , Infecciones por Moraxellaceae/microbiología , Senos Paranasales/virología , Derrame Pericárdico/microbiología , Derrame Pericárdico/cirugía , Pericarditis/microbiología , Pericarditis/cirugía , Pericardio/diagnóstico por imagen , Pericardio/microbiología , Enfermedades de Inmunodeficiencia Primaria , UltrasonografíaRESUMEN
X-linked agammaglobulinaemia (XLA) is a humoral immunodeficiency syndrome characterized from childhood by the absence of circulating B lymphocytes, absent or reduced levels of serum immunoglobulin and recurrent bacterial infections. For many affected patients, regular treatment with immunoglobulin is life saving. Hepatitis C viral (HCV) infection acquired through contaminated blood products is widely described in this patient cohort. The natural history of HCV infection in patients with XLA tends to follow a more rapid and aggressive course compared to immunocompetent individuals. Furthermore, standard anti-viral therapy appears to be less efficacious in this patient cohort. Here we report the cases of two brothers with XLA who contracted HCV through contaminated blood products. They were treated with a six month course of Interferon alpha-2b and Ribavirin. We report a sustained virologic response five years after completing treatment.
Asunto(s)
Agammaglobulinemia/virología , Antivirales/uso terapéutico , Enfermedades Genéticas Ligadas al Cromosoma X/virología , Hepatitis C/sangre , Hepatitis C/tratamiento farmacológico , Hepatitis C/prevención & control , Adulto , Agammaglobulinemia/complicaciones , Agammaglobulinemia/etiología , Agammaglobulinemia/genética , Comorbilidad , Contaminación de Medicamentos , Enfermedades Genéticas Ligadas al Cromosoma X/complicaciones , Enfermedades Genéticas Ligadas al Cromosoma X/genética , Hepatitis C/etiología , Humanos , Interferón alfa-2 , Interferón-alfa/uso terapéutico , Masculino , Proteínas Recombinantes , Recurrencia , Ribavirina/uso terapéutico , HermanosRESUMEN
Epstein-Barr virus (EBV) persists in healthy virus carriers within the immunoglobulin (Ig)D(-)CD27(+) (class-switched) memory B-cell compartment that normally arises through antigen stimulation and germinal center transit. Patients with X-linked lymphoproliferative disease (XLP) lack such class-switched memory B cells but are highly susceptible to EBV infection, often developing fatal symptoms resembling those seen in EBV-associated hemophagocytic syndrome (EBV-AHS), a disease caused by aberrant virus entry into the NK- or T-cell system. Here we show that XLP patients who survive primary EBV exposure carry relatively high virus loads in the B-cell, but not the NK- or T-cell, compartment. Interestingly, in the absence of conventional class-switched memory B cells, the circulating EBV load was concentrated within a small population of IgM(+)IgD(+)CD27(+) (nonswitched) memory cells rather than within the numerically dominant naive (IgM(+)IgD(+)CD27(-)) or transitional (CD10(+)CD27(-)) subsets. In 2 prospectively studied patients, the circulating EBV load was stable and markers of virus polymorphism detected the same resident strain over time. These results provide the first definitive evidence that EBV can establish persistence in the B-cell system in the absence of fully functional germinal center activity and of a class-switched memory B-cell compartment.
Asunto(s)
Subgrupos de Linfocitos B/virología , Herpesvirus Humano 4/inmunología , Memoria Inmunológica , Trastornos Linfoproliferativos/virología , Subgrupos de Linfocitos B/inmunología , Células Cultivadas , Infecciones por Virus de Epstein-Barr , Enfermedades Genéticas Ligadas al Cromosoma X/virología , Humanos , Cambio de Clase de Inmunoglobulina , Carga ViralRESUMEN
OBJECTIVE: To study bacteria and viruses in maxillary sinuses of patients with primary hypogammaglobulinemia receiving immunoglobulin therapy. DESIGN: Prospective cross-sectional study during 6 months. SETTING: Tertiary care university hospital. PATIENTS: Seventeen patients with primary hypogammaglobulinemia (10 males and 7 females; mean age, 39 years [age range, 11-71 years]). Sixteen patients had common variable immunodeficiency, and 1 patient had X-linked agammaglobulinemia. MAIN OUTCOME MEASURES: Magnetic resonance imaging and x-ray imaging of paranasal sinuses when patients did not have signs of acute infection and reevaluation 6 months later. Maxillary sinus aspiration and lavage were performed at a follow-up visit. Sinus fluid analysis for bacteria and viruses was performed by culture and by polymerase chain reaction. A questionnaire on symptoms related to sinusitis was administered during the follow-up period. RESULTS: Among 17 patients, 9 (53%) had radiologically defined sinusitis without subjective symptoms at study enrollment. At reevaluation 6 months later, radiological findings remained unchanged in two thirds of the patients. Among 15 patients, bacteria were found in sinus lavage samples from 13 patients, and viruses were found in samples from 7 patients. Eight patients had 2 pathogens or more on bacterial culture. Rhinovirus was identified from sinus lavage samples in 5 patients (33%), enterovirus in 3 patients (20%), and respiratory syncytial virus in 1 patient (7%). Pathogenic bacteria were found in maxillary sinuses of all patients who tested positive for rhinovirus and enterovirus. No fungi were found. During the follow-up period, 6 patients reported mucopurulent drainage. CONCLUSIONS: Bacteria and viruses were commonly found in maxillary sinuses of patients with primary hypogammaglobulinemia. Yearly evaluation by an ear, nose, and throat surgeon is recommended.
Asunto(s)
Agammaglobulinemia/microbiología , Bacterias/clasificación , Seno Maxilar/microbiología , Virus/clasificación , Adolescente , Adulto , Agammaglobulinemia/virología , Anciano , Niño , Inmunodeficiencia Variable Común/microbiología , Inmunodeficiencia Variable Común/virología , Estudios Transversales , Enterovirus/aislamiento & purificación , Femenino , Estudios de Seguimiento , Enfermedades Genéticas Ligadas al Cromosoma X/microbiología , Enfermedades Genéticas Ligadas al Cromosoma X/virología , Haemophilus influenzae/aislamiento & purificación , Humanos , Imagen por Resonancia Magnética , Masculino , Seno Maxilar/diagnóstico por imagen , Seno Maxilar/virología , Sinusitis Maxilar/microbiología , Sinusitis Maxilar/virología , Persona de Mediana Edad , Estudios Prospectivos , Radiografía , Rhinovirus/aislamiento & purificaciónRESUMEN
UNLABELLED: We have analysed the phenotype of T lymphocytes in two X-linked lymphoproliferative disease (XLP) patients with the same SH2D1A mutation differing in initial exposure to Epstein-Barr virus (EBV) and treatment. While memory T lymphocytes (with low CCR7 and CD62L expression) prevailed in both XLP patients, in patient 9, who developed acute infectious mononucleosis (AIM) and received B cell ablative treatment, the predominant phenotype was that of late effector CD8 T cells (CD27-, CD28-, CCR7-, CD62L-, CD45 RA+, perforin+), while in patient 4 (who did not suffer AIM) the prevalent phenotype of CD8 T lymphocytes was similar to that of normal controls (N) or to that of adult individuals who recovered from AIM: CD27+ , CD28+, CCR7-, CD62L-, CD45 RO+ and perforin-. CD57 expression (related to senescence) was also higher in CD8 T cells from patient 9 than in patient 4, AIM or N. Persistently high EBV viral load was observed in patient 9. The results obtained from this limited number of XLP patients suggest that events related to the initial EBV encounter (antigen load, treatment, cytokine environment) may have more weight than lack of SH2D1A in determining the long-term differentiation pattern of CD8 memory T cells.
Asunto(s)
Linfocitos T CD8-positivos/inmunología , Enfermedades Genéticas Ligadas al Cromosoma X/inmunología , Trastornos Linfoproliferativos/inmunología , Adulto , Ligando CD27/sangre , Antígenos CD28/sangre , Linfocitos T CD4-Positivos/inmunología , Preescolar , Enfermedades Genéticas Ligadas al Cromosoma X/virología , Herpesvirus Humano 4/aislamiento & purificación , Humanos , Memoria Inmunológica , Inmunofenotipificación , Mononucleosis Infecciosa/complicaciones , Mononucleosis Infecciosa/inmunología , Interferón gamma/biosíntesis , Trastornos Linfoproliferativos/virología , Masculino , Miembro 7 de la Superfamilia de Receptores de Factores de Necrosis Tumoral/sangre , Carga ViralRESUMEN
Canine X-linked severe combined immunodeficiency (XSCID) is due to mutations in the common gamma chain (gammac) gene and is identical clinically and immunologically to human XSCID, making it a true homologue of the human disease. Bone marrow-transplanted (BMT) XSCID dogs not only engraft donor T cells and reconstitute normal T-cell function but, in contrast to the majority of transplanted human XSCID patients, also engraft donor B cells and reconstitute normal humoral immune function. Shortly after our initial report of successful BMT of XSCID dogs, it soon became evident that transplanted XSCID dogs developed late-onset severe chronic cutaneous infections containing a newly described canine papillomavirus. This is analogous to the late-onset cutaneous papillomavirus infection recently described for human XSCID patients following BMT. Of 24 transplanted XSCID dogs followed for at least 1 year post-BMT, 71% developed chronic canine papillomavirus infection. Six of the transplanted dogs that developed cutaneous papillomas were maintained for >3 1/2 years post-BMT for use as breeders. Four of these six dogs (67%) developed invasive squamous cell carcinoma (SCC), with three of the dogs (75%) eventually developing metastatic SCC, an extremely rare consequence of SCC in the dog. This finding raises the question of whether SCC will develop in transplanted human XSCID patients later in life. Canine XSCID therefore provides an ideal animal model with which to study the role of the gammac-dependent signaling pathway in the response to papillomavirus infections and the progression of these viral infections to metastatic SCC.
Asunto(s)
Trasplante de Médula Ósea , Carcinoma de Células Escamosas/virología , Enfermedades de los Perros/virología , Enfermedades Genéticas Ligadas al Cromosoma X/virología , Infecciones por Papillomavirus , Inmunodeficiencia Combinada Grave/virología , Neoplasias Cutáneas/virología , Animales , Linfocitos B/patología , Linfocitos B/virología , Trasplante de Médula Ósea/efectos adversos , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/veterinaria , Enfermedad Crónica , Modelos Animales de Enfermedad , Enfermedades de los Perros/etiología , Enfermedades de los Perros/genética , Enfermedades de los Perros/patología , Perros , Femenino , Enfermedades Genéticas Ligadas al Cromosoma X/complicaciones , Enfermedades Genéticas Ligadas al Cromosoma X/genética , Enfermedades Genéticas Ligadas al Cromosoma X/patología , Enfermedades Genéticas Ligadas al Cromosoma X/veterinaria , Humanos , Masculino , Metástasis de la Neoplasia/patología , Infecciones por Papillomavirus/etiología , Infecciones por Papillomavirus/patología , Infecciones por Papillomavirus/veterinaria , Inmunodeficiencia Combinada Grave/complicaciones , Inmunodeficiencia Combinada Grave/genética , Inmunodeficiencia Combinada Grave/patología , Inmunodeficiencia Combinada Grave/terapia , Inmunodeficiencia Combinada Grave/veterinaria , Transducción de Señal/genética , Neoplasias Cutáneas/patología , Linfocitos T/patología , Linfocitos T/virología , Factores de Tiempo , Trasplante HeterólogoRESUMEN
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that persists in the body for life after primary infection. The primary site of EBV persistence is the memory B lymphocyte, but whether the virus initially infects naïve or memory B cells is still disputed. We have analyzed EBV infection in nine cases of X-linked hyper-immunoglobulin M (hyper-IgM) syndrome who, due to a mutation in CD40 ligand gene, do not have a classical, class-switched memory B-cell population (IgD(-) CD27(+)). We found evidence of EBV infection in 67% of cases, which is similar to the infection rate found in the general United Kingdom population (60 to 70% for the relevant age range). We detected EBV DNA in peripheral blood B cells and showed in one case that the infection was restricted to the small population of nonclassical, germinal center-independent memory B cells (IgD(+) CD27(+)). Detection of EBV small RNAs, latent membrane protein 2, and EBV nuclear antigen 3C expression in peripheral blood suggests full latent viral gene expression in this population. Analysis of EBV DNA in serial samples showed variability over time, suggesting cycles of infection and loss. Our results demonstrate that short-term EBV persistence can occur in the absence of a germinal center reaction and a classical memory B-cell population.